UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"

Not Applicable

Completed

Conditions: Patient Compliance
Acne

Interventions: Other: Text message reminders

First Posted Date: 2010-03-08

Last Posted Date: 2019-09-17

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 40

Registration Number: NCT01082523

Locations: 🇺🇸
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, United States

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Phase 1

Withdrawn

Conditions: Prostate Cancer

Interventions: Drug: ixabepilone
Procedure: adjuvant therapy
Radiation: intensity-modulated radiation therapy

First Posted Date: 2010-03-03

Last Posted Date: 2020-08-20

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT01079793

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy

Not Applicable

Completed

Conditions: Peanut Allergy

Interventions: Other: Peanut flour

First Posted Date: 2010-02-24

Last Posted Date: 2014-12-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 12

Registration Number: NCT01074840

Locations: 🇺🇸
Children's Medical Center Dallas Food Allergy Center, Dallas, Texas, United States

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Phase 1

Withdrawn

Conditions: Pre-hypertension
Hypertension

Interventions: Drug: Potassium, Magnesium, Citrate
Drug: Potassium Chloride

First Posted Date: 2010-02-24

Last Posted Date: 2019-02-11

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT01074918

Locations: 🇺🇸
Dallas VA Medical Center, Dallas, Texas, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Radiation: stereotactic body radiation therapy
Drug: gemcitabine hydrochloride

First Posted Date: 2009-12-04

Last Posted Date: 2019-02-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 5

Registration Number: NCT01025882

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Other: Observation
Drug: Pioglitazone

First Posted Date: 2009-12-02

Last Posted Date: 2019-10-08

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 4

Registration Number: NCT01023620

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

NARCOMS Registry: a Multiple Sclerosis Registry

Recruiting

Conditions: Multiple Sclerosis

First Posted Date: 2009-11-23

Last Posted Date: 2024-11-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 50000

Registration Number: NCT01018537

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)

Phase 1

Completed

Conditions: Venous Thromboembolism
Traumatic Brain Injury

Interventions: Drug: enoxaparin
Drug: placebo

First Posted Date: 2009-11-17

Last Posted Date: 2021-01-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 62

Registration Number: NCT01014403

Locations: 🇺🇸
UT-Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
East Texas Medical Center, Tyler, Texas, United States

The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart

Phase 2

Completed

Conditions: Ventricular Function

Interventions: Behavioral: Aerobic Exercise Training
Behavioral: Tai Chi and/or Yoga Training

First Posted Date: 2009-11-17

Last Posted Date: 2020-08-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 62

Registration Number: NCT01014572

Locations: 🇺🇸
The Institute for Exercise and Environmental Medicine, Dallas, Texas, United States

Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery

Phase 1

Completed

Conditions: Stroke

Interventions: Device: tDCS

First Posted Date: 2009-11-17

Last Posted Date: 2020-04-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 14

Registration Number: NCT01014897

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy